The regulatory process for much-ballyhooed Macugen is under way.Partners Eyetech Pharmaceuticals Inc. and Pfizer Inc. completed their submission of a new drug application with the FDA, applying for use of the potential blockbuster in wet age-related macular degeneration. (BioWorld Today)